Jove
Visualize
Contact Us

Related Experiment Videos

Hormone replacement therapy. Risks, benefits, and costs

M D Delva1

  • 1Department of Family Medicine, Queen's University, Kingston, Ont.

Canadian Family Physician Medecin De Famille Canadien
|October 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indications for Vitamin B(12) Therapy: A retrospective study.

Canadian family physician Medecin de famille canadien·2010
Same author

Vitamin B12 replacement. To B12 or not to B12?

Canadian family physician Medecin de famille canadien·1997
Same author

General practice training in the Oxford region. Ideas for community teaching practices.

Canadian family physician Medecin de famille canadien·1995
Same author

Herpes genitalis in a student population.

The Journal of family practice·1984
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Hormone replacement therapy (HRT) shows potential cardiovascular benefits for postmenopausal women, but risks require careful consideration. Further research is needed before widespread adoption, especially for osteoporosis prevention.

Area of Science:

  • Reproductive Medicine
  • Cardiovascular Health
  • Bone Metabolism

Background:

  • Accumulating epidemiologic evidence on hormone replacement therapy (HRT) for postmenopausal women.
  • HRT is associated with a potential 50% reduction in cardiovascular mortality risk.
  • The decision regarding HRT use involves weighing risks and benefits.

Purpose of the Study:

  • To review the current epidemiologic evidence on the risks and benefits of HRT in postmenopausal women.
  • To inform clinical decision-making regarding HRT use.
  • To guide women considering HRT for osteoporosis prevention.

Main Methods:

  • Review of existing epidemiologic studies on hormone replacement therapy.
  • Analysis of data regarding cardiovascular mortality and osteoporosis risk.

Related Experiment Videos

  • Consideration of the need for prospective, controlled trials.

    • Main Results:

    • Epidemiologic data suggest a significant reduction in cardiovascular mortality risk with HRT.
    • The overall consequences of HRT require thorough consideration.
    • Bone mass estimation may be beneficial for women considering HRT solely for osteoporosis.

    Conclusions:

    • The decision to use HRT should be individualized, considering all potential consequences.
    • Prospective, controlled trials are essential to definitively establish the risks and benefits of HRT.
    • Bone density assessment may aid in the decision-making process for women primarily concerned about osteoporosis.